Experience

• • Clayton, Dubilier & Rice in its strategic partnership with Elevance Health, which will bring together certain care delivery and enablement assets of Elevance’s Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group.
  • Konica Minolta, a Japanese multinational equipment and materials manufacturer operating in the healthcare and industrial industries, in the sale of its subsidiary Invicro to Calyx, a portfolio company of CapVest and leading technology-enabled provider.
  • Temasek as capital provider in the $1.5 billion take-private acquisition of SP Plus Corporation by Metropolis Technologies.
  • INDICOR, a Clayton, Dubilier & Rice portfolio company, in the $670 million sale of its Compressor Controls Corporation division, a leading provider of turbomachinery control and optimization solutions, to Honeywell.
  • Carlyle, in collaboration with its life sciences franchise Abingworth and their development company Launch Tx, in its investment of up to $170 million in biopharmaceutical company Opthea Limited.
  • J.P. Morgan Securities, as financial advisor to multi-cloud services provider VMware, in its sale to global technology leader Broadcom, in a transaction valued at approximately $61 billion.
  • Carlyle in its acquisition of Abingworth, a transatlantic life sciences investment firm with over $2 billion in assets under management.
  • Carlyle in its investment in Resonetics, a leader in micro-manufacturing for the medical device and diagnostics equipment industries, valuing the company at approximately $2.25 billion.
  • Carlyle in its strategic growth investment and acquisition of a majority stake in Saama, a leading AI-driven intelligent clinical cloud company that enables the life sciences industry to conduct faster and safer clinical developments and regulatory programs, valuing the company at up to $430 million.
  • Clayton, Dubilier & Rice in its acquisition of PwC’s Global Mobility Tax and Immigration Services practice, the global leader in employee tax, immigration, business travel, cross-border managed services, and payroll solutions to multinational organizations and their employees.
  • HCA Healthcare, one of the nation’s leading provider of healthcare services, in its agreement to acquire the operations of five hospitals of Steward Health Care, the largest physician-led healthcare network.
  • HCA Healthcare, one of the nation’s leading provider of healthcare services, in its agreement to divest certain assets from its joint venture with Brookdale Health Care Services to LHC Group, a national provider of in-home healthcare.
  • Blackstone as a lead investor in the formation of Hydrogen Health.
  • HCA Healthcare in its acquisition of a majority stake in Brookdale Health Care Services, the home health, hospice and outpatient therapy business of Brookdale Senior Living.
  • Carlyle in its $2.6 billion sale of MedRisk to CVC Capital Partners.
  • HealthEdge and its controlling shareholder, Blackstone, in the acquisition of Altruista, a care management software company that delivers care management and population health management solutions that support value-based and person-centered care models.
  • Carlyle in its majority investment in TriNetX, a leading global health research network optimizing clinical research to bring new therapies to market faster.
  • Carlyle in its $175 million investment in Grand Rounds, a leader in healthcare quality and clinical navigation.
  • HealthEdge and its controlling shareholder, Blackstone, in the acquisition of The Burgess Group, an innovative payment integrity software company focused on improving healthcare payment operations through a cloud-based technology platform.
  • Blackstone in its acquisition of HealthEdge, a leading technology business that delivers next generation Core Administrative Processing Systems (CAPS) solutions to healthcare businesses.
  • Allergan in its sale of Brazikumab to AstraZeneca and Zenpep to Nestle.
  • J.C. Flowers and AmeriLife Group in the sale of AmeriLife to Thomas H. Lee Partners.
  • Johnson & Johnson in its acquisition of TARIS, a biotechnology company specializing in the development of a novel drugs and delivery technologies for the treatment of cancer.
  • Carlyle in its investment in American Express Global Business Travel. (Terminated)
  • Clayton, Dubilier & Rice in its proposed $4 billion take private acquisition of Anixter International, a NYSE-listed company. (Terminated)
  • Kelso & Company in its acquisition of a majority equity interest in Individual FoodService from Sole Source Capital.
  • Prudential Financial in its $2.35 billion acquisition of Assurance IQ.
  • Bain Capital Private Equity and Diamond Castle in the sale of Beacon Health Options to Anthem.
  • KeyBank in its acquisition of Laurel Road’s affinity-focused digital lending business.
  • HCA Healthcare in its $1.5 billion acquisition of Mission Health, a nonprofit North Carolina health system.
  • Johnson & Johnson in its acquisition of Zarbee's Naturals, a leader in naturally-based healthcare products.
  • Johnson & Johnson in its sale of Nizoral’s EMEA rights to STADA Arzneimittel AG; LATAM rights to Kramer Laboratories; and APAC rights to Alliance Pharmaceuticals Limited.
  • TPG and Welsh, Carson, Anderson & Stowe, with Humana, in their $1.4 billion acquisition of Curo Health Services.
  • Carlyle in its strategic minority investment in DiscoverOrg, the leading global sales and marketing intelligence platform.
  • TPG and Welsh, Carson, Anderson & Stowe in the $4.1 billion acquisition of Kindred Healthcare.
  • CVC Capital Partners in its investment in Republic Finance, a consumer loan provider.
  • Mitsui in its acquisition of an additional 10% limited partnership interest in Penske Truck Leasing from subsidiaries of GE Capital Global Holdings.
  • CF Corporation and Blackstone in the $1.835 billion acquisition of Fidelity & Guaranty Life.
  • Allergan in its $2.47 billion acquisition of ZELTIQ, a medical technology company focused on utilizing its proprietary CoolSculpting controlled-cooling technology platform, the sales leader in the fast-growing body contouring segment of medical aesthetics.
  • Johnson & Johnson in its purchase of an exclusive option to acquire Bird Rock Bio, a clinical stage biopharmaceutical company focused on innovative immuno-inflammatory regulators that can be used in the treatment of liver disease.
  • Allergan in its $2.9 billion acquisition of LifeCell Corporation, a regenerative medicine business.
  • Allergan in its global collaboration agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic.
  • Lannett in its acquisition for $1.23 billion in cash, plus additional contingent consideration, of Kremers Urban Pharmaceuticals, the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB.
  • Apollo Global Management in its acquisition of a majority interest in the asset management business of AR Capital (subsequently withdrawn), its acquisition of the wholesale distribution business of RCS Capital and its substantial minority equity investment in RCS Capital. (Terminated)
  • Stone Point Capital in its investment in Millstein & co., a diversified financial services firm.
  • Actavis in the sale of Aptalis Pharmaceutical Technologies, a pharmaceutical outsourcing and R&D business in the U.S., to TPG.
  • Actavis in the sale of its branded respiratory business in the U.S. and Canada to AstraZeneca for $600 million, and an additional payment of $100 million relating to certain other agreements.
  • New York Life Investments in its acquisition of IndexIQ, a leader in the liquid alternative exchange-traded fund industry.
  • Blackstone Group’s Tactical Opportunities Group in the acquisition of Philadelphia Financial Group from Tiptree Financial.
  • Chemtura in the $1 billion sale of its agrochemicals business, Chemtura AgroSolutions.
  • Johnson & Johnson in the sale of its worldwide intimate health business to Reckitt Benckiser, a UK-based consumer goods company.
  • Warner Music Group in its $765 million acquisition of the Parlophone Label Group from Universal Music Group.
  • PSAV, a Kelso & Company portfolio company, in its acquisition by affiliates of Goldman Sachs.
  • The Special Committee of the Board of Directors of Dell in litigation challenging the $24.9 billion sale of Dell to an investor group including Michael Dell and Silver Lake.
  • Goldman Sachs Reinsurance Group in its acquisition of the Bermuda-based reinsurance operations of Ariel Holdings.
  • Clayton, Dubilier & Rice in its acquisition of a 60% stake in Hussmann International, a leading global manufacturer of refrigerated display merchandizing equipment and refrigeration systems for the retail food industry, from Ingersoll Rand.
  • Cunningham Lindsey in its acquisition of GAB Robins North America's U.S. loss adjusting business.